Potential microRNA-mediated oncogenic intercellular communication revealed by pan-cancer analysis

被引:14
|
作者
Li, Yue [1 ,2 ]
Zhang, Zhaolei [1 ,2 ,3 ,4 ]
机构
[1] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3G4, Canada
[2] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada
[3] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada
[4] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada
来源
SCIENTIFIC REPORTS | 2014年 / 4卷
基金
加拿大自然科学与工程研究理事会;
关键词
EXPRESSION PROFILES; TARGET; IDENTIFICATION; SIGNATURES; MUTATIONS; RNAS;
D O I
10.1038/srep07097
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Carcinogenesis consists of oncogenesis and metastasis, and intriguingly microRNAs (miRNAs) are involved in both processes. Although aberrant miRNA activities are prevalent in diverse tumor types, the exact mechanisms for how they regulate cancerous processes are not always clear. To this end, we performed a large-scale pan-cancer analysis via a novel probabilistic approach to infer recurrent miRNA-target interactions implicated in 12 cancer types using data from The Cancer Genome Atlas. We discovered similar to 20,000 recurrent miRNA regulations, which are enriched for cancer-related miRNAs/genes. Notably, miRNA 200 family (miR-200/141/429) is among the most prominent miRNA regulators, which is known to be involved in metastasis. Importantly, the recurrent miRNA regulatory network is not only enriched for cancer pathways but also for extracellular matrix (ECM) organization and ECM-receptor interactions. The results suggest an intriguing cancer mechanism involving miRNA-mediated cell-to-cell communication, which possibly involves delivery of tumorigenic miRNA messengers to adjacent cells via exosomes. Finally, survival analysis revealed 414 recurrent-prognostic associations, where both gene and miRNA involved in each interaction conferred significant prognostic power in one or more cancer types. Together, our comprehensive pan-cancer analysis provided not only biological insights into metastasis but also brought to bear the clinical relevance of the proposed recurrent miRNA-gene associations.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Pan-cancer analysis and the oncogenic role of Glypican 1 in hepatocellular carcinoma
    Cao, Li
    Li, Fang
    Cai, Shuang
    Zhang, Jinyuan
    Guo, Chen
    Ali, Sadiq
    Zhou, Jing
    Jing, Xintao
    Wang, Xiaofei
    Qin, Yannan
    Wu, Fei
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [22] Comprehensive Pan-Cancer Analysis of Oncogenic ERBB2 Fusions
    Marti, J. Gomez
    Zhang, T.
    Aldana, C. Febres
    Cheng, R.
    Mattar, M.
    Gili, L.
    Master, R.
    Liu, Z.
    Ladanyi, M.
    Somwar, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S99 - S99
  • [23] A pan-cancer analysis of the oncogenic role of ERCC6L
    Zhimin Lu
    Lihong Fei
    Guoxin Hou
    BMC Cancer, 22
  • [24] Pan-Cancer Analysis on the Oncogenic Role of Programmed Cell Death 10
    Sun, Ning
    Li, Chenchen
    Teng, Yue
    Deng, Yuxia
    Shi, Lin
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [25] Pan-Cancer Analysis of the Oncogenic and Immunological Role of RCN3: A Potential Biomarker for Prognosis and Immunotherapy
    Ding, Jian
    Meng, Yan
    Han, Zelong
    Luo, Xiaobei
    Guo, Xuxue
    Li, Yiwen
    Liu, Side
    Zhuang, Kangmin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] Pan-Cancer Analysis of the Oncogenic and Prognostic Role of PKM2: A Potential Target for Survival and Immunotherapy
    Liang, Nan
    Mi, Lusi
    Li, Jingting
    Li, Tong
    Chen, Jun
    Dionigi, Gianlorenzo
    Guan, Haixia
    Sun, Hui
    BIOMED RESEARCH INTERNATIONAL, 2023, 2023
  • [27] Analysis of Pan-Cancer Revealed the Immunological and Prognostic Potential of CBX3 in Human Tumors
    Xu, Haitao
    Jiang, Caihong
    Chen, Dangui
    Wu, Youzhi
    Lu, Jia
    Zhong, Long
    Yao, Fusheng
    FRONTIERS IN MEDICINE, 2022, 9
  • [28] Pan-cancer analysis of LINC02535 as a potential biomarker and its oncogenic role in lung adenocarcinoma
    Dai, Shuang
    Liu, Tao
    He, Ying-Ying
    Huang, Yan
    Wang, Li
    Luo, Feng
    Li, Yan
    HELIYON, 2022, 8 (12)
  • [29] A Pan-Cancer Analysis of the Oncogenic Role of BCL7B: A Potential Biomarker for Prognosis and Immunotherapy
    Yang, Dinglong
    Li, Hetong
    Chen, Yujing
    Li, Chunjiang
    Ren, Weiping
    Huang, Yongbo
    FRONTIERS IN GENETICS, 2022, 13
  • [30] MicroRNA-mediated regulation of KRAS in cancer
    Kim, Minlee
    Slack, Frank J.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 7